CITRIC ACID,ALPHA-HYDROXY: (-): (4323)

Compound Details

NameCITRIC ACID,ALPHA-HYDROXY: (-):
Compound class11005E711
Compound codeALKANE TO C4

Synonyms

CITRIC ACID,HYDROXY:viewCITRIC ACID,ALPHA-HYDROXY:viewCITRIC ACID,HYDROXY: (-):view

Summary

Compound class: 11005E711

Experiments: 79

View Experiments

Experiments (79)

Filters
Worktypes (17)
36
13
11
10
6
6
3
2
2
2
2
2
1
1
1
1
1
No match
Pharmacology (34)
7
5
5
4
4
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
18
No match
Compounds (8)
79
2
1
1
1
1
1
1
No match
Organisms (52)
7
6
4
4
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
79 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
808232
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
762474
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
1037161
ISOLATION AND IDENTIFICATION OF
Garcinia indica (CLUSIACEAE)
68849
PHARMACOLOGY OF COMPOUND - IN HUMANS
APPETITE SUPPRESSANT
Empty organism
796964
DRUG-DRUG INTERACTION IN VITROPHARMACOLOGY OF COMPOUND - IN HUMANS
WOUND HEALING ACCELERATION
Empty organism
428253
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT GAIN INHIBITION
Empty organism
60881
PHARMACOLOGY OF COMPOUND - IN VIVO
LIPOGENESIS INHIBITION
Empty organism
429340
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERTRIGLYCERIDEMIA EFFECT
Empty organism
65611
PHARMACOLOGY OF COMPOUND - IN VIVO
FATTY ACID SYNTHESIS INHIBITION
Empty organism
60501
PHARMACOLOGY OF COMPOUND - IN VIVO
FATTY ACID SYNTHESIS INHIBITION
Empty organism
635125
PHARMACOLOGY OF COMPOUND - IN HUMANS
WEIGHT LOSS
Empty organism
762889
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT GAIN INHIBITION
Empty organism
429341
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERTRIGLYCERIDEMIA EFFECT
Empty organism
807073
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT LOSS
Empty organism
68915
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOBESITY ACTIVITY
Empty organism
64641
PHARMACOLOGY OF COMPOUND - IN VIVO
FATTY ACID SYNTHESIS INHIBITION
Empty organism
740073
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
60484
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT GAIN INHIBITION
Empty organism
808233
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Empty organism
1282816
PHARMACOLOGY OF COMPOUND - IN HUMANS
HYPOGLYCEMIC ACTIVITY
Empty organism
60878
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPOGENESIS INHIBITION
Empty organism
762890
PHARMACOLOGY OF COMPOUND - IN VIVO
BETA-HYDROXYBUTYRATE LEVEL INHIBITION
Empty organism
68860
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOBESITY ACTIVITY
Empty organism
19537
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Hibiscus cannabinus (MALVACEAE)
60880
PHARMACOLOGY OF COMPOUND - IN VIVO
LIPOGENESIS INHIBITION
Empty organism
1290391
PHARMACOLOGY OF EXTRACT - IN HUMANS
LIPOGENESIS INHIBITION
Empty organism
808231
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
67378
PHARMACOLOGY OF COMPOUND - IN HUMANS
FATTY ACID OXIDATION STIMULATION
Empty organism
60884
PHARMACOLOGY OF COMPOUND - IN VIVO
FATTY ACID SYNTHESIS INHIBITION
Empty organism
519775
PHARMACOLOGY OF COMPOUND - IN VITRO
CITRATE LYASE INHIBITION
Empty organism
60502
PHARMACOLOGY OF COMPOUND - IN VITRO
FATTY ACID SYNTHESIS STIMULATION
Empty organism
610901
ISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
710287
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDHPLC SEPARATION DATA FORISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
60879
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPOGENESIS INHIBITION
Empty organism
659841
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Garcinia cambogia (CLUSIACEAE)
60895
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTILIPOGENIC ACTIVITY
Empty organism
512055
PHARMACOLOGY OF COMPOUND - IN VITRO
CITRATE LYASE INHIBITION
Empty organism
796965
DRUG-DRUG INTERACTION IN VITROPHARMACOLOGY OF COMPOUND - IN HUMANS
IMMUNOMODULATOR ACTIVITY
Empty organism
636859
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT LOSS
Empty organism
428252
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT GAIN INHIBITION
Empty organism
401473
IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
746620
PRESENT IN (REVIEW)REVIEW OF
Garcinia cambogia (CLUSIACEAE)
1282817
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIHYPERGLYCEMIC(ANTIDIABETIC) ACTIVITY
Empty organism
68865
PHARMACOLOGY OF COMPOUND - IN HUMANS
MISCELLANEOUS EFFECTS
Empty organism
670710
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
WEIGHT LOSS
Garcinia cambogia (CLUSIACEAE)
762888
PHARMACOLOGY OF COMPOUND - IN VIVO
FOOD CONSUMPTION REDUCTION
Empty organism
681300
PHARMACOLOGY OF COMPOUND - IN VIVO
WEIGHT GAIN INHIBITION
Empty organism
60503
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTEROL SYNTHESIS INHIBITION
Empty organism
429344
PHARMACOLOGY OF COMPOUND - IN VIVO
LIPOGENESIS INHIBITION
Empty organism
678077
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Garcinia cambogia (CLUSIACEAE)
68034
PHARMACOLOGY OF COMPOUND - IN HUMANS
BODY WEIGHT LOSS INHIBITION
Empty organism
762891
PHARMACOLOGY OF COMPOUND - IN VIVO
TRIACYLGLYCEROL LEVEL INHIBITION
Empty organism
65613
PHARMACOLOGY OF COMPOUND - IN VIVO
GLYCOGENESIS STIMULATION
Empty organism
426676
PHARMACOLOGY OF COMPOUND - IN VIVO
FEEDING DETERRENT(ANIMAL)
Empty organism
65536
COMPLETE SYNTHESIS REPORTED
Empty organism
585591
PHARMACOLOGY OF COMPOUND - IN VITRO
ADENOSINE-TRIPHOSPHATE-CITRATE LYASE INHIBITION
Empty organism
746084
PHARMACOLOGY OF COMPOUND - IN VITRO
SEROTONIN (5-HT) RELEASING EFFECT
Empty organism
693613
PHARMACOLOGY OF COMPOUND - IN VIVO
MISCELLANEOUS EFFECTS
Empty organism
1282814
PHARMACOLOGY OF COMPOUND - IN HUMANS
ANTIOXIDANT ACTIVITY
Empty organism
429343
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHYPERTRIGLYCERIDEMIA EFFECT
Empty organism
60883
PHARMACOLOGY OF COMPOUND - IN VIVO
CHOLESTEROL SYNTHESIS INHIBITION
Empty organism
69583
PATENT DESCRIBEDPHARMACOLOGY OF COMPOUND - IN HUMANS
MISCELLANEOUS EFFECTS
Empty organism
285497
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Beta vulgaris (CHENOPODIACEAE)
20527
ISOLATION AND IDENTIFICATION OF
Garcinia indica (CLUSIACEAE)
429339
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOTRIGLYCERIDEMIA ACTIVITY
Empty organism
65612
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOCHOLESTEROLEMIC ACTIVITY
Empty organism
60500
PHARMACOLOGY OF COMPOUND - IN VIVO
CHOLESTEROL SYNTHESIS INHIBITION
Empty organism
428254
PHARMACOLOGY OF COMPOUND - IN VIVO
CITRATE LYASE INHIBITION
Empty organism
432030
PRESENT IN (REVIEW)
Garcinia cambogia (CLUSIACEAE)
429342
PHARMACOLOGY OF COMPOUND - IN VIVO
FATTY ACID CONTENT DECREASE
Empty organism
670709
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
376991
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION IN BY HPLCQUANTITATIVE DATAHPLC SEPARATION DATA FOR
Garcinia cambogia (CLUSIACEAE)
64640
PHARMACOLOGY OF COMPOUND - IN VITRO
FATTY ACID SYNTHESIS INHIBITION
Empty organism
512054
PHARMACOLOGY OF COMPOUND - IN VITRO
LDL RECEPTOR BINDING STIMULATION
Empty organism
20528
ISOLATION AND IDENTIFICATION OF
Garcinia atroviridis (CLUSIACEAE)
69128
PHARMACOLOGY OF COMPOUND - IN VIVOPATENT DESCRIBED
ANTIOSTEOPOROSIS ACTIVITY
Empty organism
65237
PHARMACOLOGY OF COMPOUND - IN VITRO
CITRATE LYASE INHIBITION
Empty organism
20526
ISOLATION AND IDENTIFICATION OF
Garcinia cambogia (CLUSIACEAE)
60882
PHARMACOLOGY OF COMPOUND - IN VIVO
LIPOGENESIS INHIBITION
Empty organism
Show SPARQL Queries (1)